The cannabis market has continued to astound investors with its massive amount of growth over the past few months to years. In recent times, many stocks have benefitted from new legislation around the world and specifically Canada. Many of the top companies in the industry have been cited as being massive innovators for the market, and continue to attract new and necessary money to the space as a whole.
One of the primary players and one that should come as no surprise is the company Canopy Growth Corporation (NYSE:CGC). The company states that they are a “world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and soft gel capsule forms.” The company recently made headlines after signing an agreement with Constellation Brands (NYSE:STZ), a major alcohol distributor and producer, which will help the two to create new products in the long run. The introduction of alcohol companies like these has been one of the major breakthroughs in the cannabis space of recent, and has been propagated by lower sales of alcohol, and a high demand for cannabis-infused beverages. In other news with the company, “ it has received amended licenses from Health Canada that increase the size and sophistication of its national footprint. The amended licenses include a nearly doubling of growing capacity at its Smiths Falls Campus at 1 Hershey Drive, an additional 223,200 sq. ft. of cultivation space at its majority-owned Les Serres Vert Cannabis Inc. greenhouse in Mirabel, Quebec, and a license for a highly automated, state-of-the-art Distribution Centre located at its Smiths Falls campus.” The hopes are that this new growing space will help them to continue meeting demands for the cannabis industry as a whole.
The next company on the list and another one of the big players has been that of Tilray (NASDAQ:TLRY). The company has been a “global pioneer in cannabis research, cultivation, processing and distribution currently serving tens of thousands of patients in eleven countries spanning five continents.” The company has also been working with several liquor distributors to determine how to advance with a new investment from the market. The company is poised perfectly as well to take advantage of the recreational market in Canada that will go into effect on October 17th. Tilray remains one of the important stocks to watch in the cannabis space for the near future.
The last company on the list is the company GT Biopharma Inc (GTBP). GT Biopharma has been one of the more important players working on creating new medicines using components from the cannabis plant. The company has been cited as being one of the primary researchers on creating new drugs for various types of cancer research and treatment. The space on bioengineering with cannabis substances has become a massive part of the market share, and companies within this space are continuing to innovate and bring new ideas into the industry. GT Biopharma remains one of the main innovators in the pharmaceutical side of the cannabis market.
The hopes are high that over the course of the next few months to years, the cannabis space can continue its reign of success. Only time will tell how well this new legislation allows for more growth in the market.
Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and GT Biopharma, Midam has been paid $200,000 from the company and ZERO shares of GT Biopharma Inc. for a duration beginning July 16, 2018 and ending August 16, 2018. Midam Ventures has been paid an additional $200k by GT Biopharma and has extended its marketing period through Sept 16, 2018. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
